A 42-year-old man with a history of peptic ulcer disease is given a muscarinic antagonist for symptom relief. His colleague asks: 'Why does this drug block gastric acid secretion, whereas a β-blocker would not?' Which second-messenger pathway best explains this difference?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.